InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: None

Monday, 09/02/2019 8:03:35 PM

Monday, September 02, 2019 8:03:35 PM

Post# of 425622
North, I can't respond to you in a private message. I should not have said Reduce-it Patents. I should have said results from Reduce-It trials. John Thero said at the BMO conference that "The court has allowed us to introduce the results of the REDUCE-IT study, which we think supports the uniqueness of Vascepa." I think that is a benefit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News